# Pioglitazone in Thyroid Cancers

> **NCT01655719** · PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 1 (actual)

## Conditions studied

- Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT01655719
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01655719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01655719, "Pioglitazone in Thyroid Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01655719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*